RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price rose 1.2% during trading on Wednesday . The company traded as high as GBX 1.26 ($0.02) and last traded at GBX 1.26 ($0.02). Approximately 495,137 shares changed hands during mid-day trading, an increase of 129% from the average daily volume of 215,884 shares. The stock had previously closed at GBX 1.25 ($0.02).
RTW Biotech Opportunities Price Performance
The firm’s fifty day moving average is GBX 1.34 and its 200-day moving average is GBX 1.44. The firm has a market cap of £416.53 million, a price-to-earnings ratio of 2.96 and a beta of 0.60.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW or RTWG) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Biotech Opportunities invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives.
Recommended Stories
- Five stocks we like better than RTW Biotech Opportunities
- Short Selling: How to Short a Stock
- FedEx Delivers Another Crushing Blow to Its Stock Price
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- What Are Earnings Reports?
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
